Deal volumes and values are tracking above the first half of 2025, driven by Boston Scientific’s Penumbra buyout and ...
In mid-June 2026, Johnson & Johnson reported strong clinical data for TALVEY combinations in relapsed/refractory multiple ...
Analysts remain relatively more upbeat, but this could prove fleeting.
Star51 Capital announced today that it completed the first close of its inaugural fund for early- and growth-stage medtech ...
Learn how medtech startups use equity crowdfunding platforms like Wefunder to raise capital, validate demand, and build ...
Sanara MedTech is back in focus as the consensus fair value estimate edges from US$34.00 to about US$34.33 per share, giving investors a refreshed reference point for the stock. That small move lines ...
One of the more counterintuitive lessons I've learned in medtech is that your closest competitor could also be your best potential partner, distributor or acquirer. Early on, I thought competitors ...
Wipfli's Cara Walton explains how vertical integration drives medtech consolidation for better margins. Ever wonder why there ...
MedtechWOMEN to convene industry leaders at MedtechVISION 2026 capital, AI and geopolitics reshape medtech —Nationally recognized health ...
Discover how Astoria-Pacific International leveraged the Carbon platform to bring a groundbreaking manufacturing solution to ...
Kerala has been actively promoting knowledge-driven industries. How important do you see MedTech becoming within the state’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results